LLY
1,069.44
+0.7%↑
JNJ
208.01
-0.26%↓
ABBV
226.07
+0.71%↑
UNH
333.57
+1.87%↑
AZN
91.61
+0.99%↑
LLY
1,069.44
+0.7%↑
JNJ
208.01
-0.26%↓
ABBV
226.07
+0.71%↑
UNH
333.57
+1.87%↑
AZN
91.61
+0.99%↑
LLY
1,069.44
+0.7%↑
JNJ
208.01
-0.26%↓
ABBV
226.07
+0.71%↑
UNH
333.57
+1.87%↑
AZN
91.61
+0.99%↑
LLY
1,069.44
+0.7%↑
JNJ
208.01
-0.26%↓
ABBV
226.07
+0.71%↑
UNH
333.57
+1.87%↑
AZN
91.61
+0.99%↑
LLY
1,069.44
+0.7%↑
JNJ
208.01
-0.26%↓
ABBV
226.07
+0.71%↑
UNH
333.57
+1.87%↑
AZN
91.61
+0.99%↑
24u
Huidig
Min
31.44
Max
32.8
Inkomsten | 66M -35M |
|---|---|
Verkoop | 70M 71M |
Winstmarge | -49.028 |
Werknemers | 143 |
EBITDA | 66M -34M |
Aanbevelingen | Strong Buy |
|---|---|
12 Maanden Prognose | +27.2% upside |
Marktkapitalisatie | 997M 3.2B |
|---|---|
Vorige openingsprijs | 31.15 |
Vorige sluitingsprijs | 32.03 |
By Acuity
50%
50%
167 / 374 Rangschikking in Healthcare
By Trading Central
Vertrouwen
Very Strong Bearish Evidence
12 / 13.14 Steun & Weerstand
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
18 dec 2025, 23:54 UTC
Stocks to Watch: Nike, Cassava Sciences, KB Home
DJ
Lezen
18 dec 2025, 23:51 UTC
Nike Sales Tick Up in 2Q; China Weakness Persists -- Update
DJ
Lezen
18 dec 2025, 23:39 UTC
Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial
DJ
Lezen
18 dec 2025, 22:57 UTC
TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo
DJ
Lezen
18 dec 2025, 21:40 UTC
Nike Sales Tick Up, But China Weakness Persists
DJ
Lezen
18 dec 2025, 23:45 UTC
Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk
DJ
Lezen
18 dec 2025, 23:37 UTC
Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk
DJ
Lezen
18 dec 2025, 23:36 UTC
Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk
DJ
Lezen
18 dec 2025, 23:03 UTC
Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial
DJ
Lezen
18 dec 2025, 23:02 UTC
Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.
DJ
Lezen
18 dec 2025, 23:00 UTC
Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.
DJ
Lezen
18 dec 2025, 22:59 UTC
Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material
DJ
Lezen
18 dec 2025, 22:58 UTC
SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com
DJ
Lezen
18 dec 2025, 22:57 UTC
Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.
DJ
Lezen
18 dec 2025, 22:56 UTC
Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD
DJ
Lezen
18 dec 2025, 22:55 UTC
Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com
DJ
Lezen
18 dec 2025, 21:59 UTC
Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com
DJ
Lezen
18 dec 2025, 21:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Lezen
18 dec 2025, 21:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lezen
18 dec 2025, 21:35 UTC
FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com
DJ
Lezen
18 dec 2025, 21:31 UTC
Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com
DJ
Lezen
18 dec 2025, 21:15 UTC
Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE
DJ
Lezen
18 dec 2025, 21:15 UTC
Nike 2Q Greater China Rev Down 17% >NKE
DJ
Lezen
18 dec 2025, 21:15 UTC
Nike 2Q EPS 53c >NKE
DJ
Lezen
18 dec 2025, 21:15 UTC
Nike 2Q Apparel Rev $3.91B >NKE
DJ
Lezen
18 dec 2025, 21:15 UTC
Nike 2Q Equipment Rev $550M >NKE
DJ
Lezen
18 dec 2025, 21:15 UTC
Nike 2Q N Amer Rev $5.63B >NKE
DJ
Lezen
18 dec 2025, 21:15 UTC
Nike 2Q Footwear Rev $7.66B >NKE
DJ
Lezen
18 dec 2025, 21:15 UTC
Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE
DJ
Lezen
18 dec 2025, 21:15 UTC
Nike 2Q Greater China Rev $1.42B >NKE
DJ
Lezen
Prijswijziging
By TipRanks
12 Maanden Prognose
Gemiddelde 40.87 USD 27.2%
Hoogste 61 USD
Laagste 14.29 USD
Gebaseerd op 16 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.
By TipRanks
Strong Buy
16 ratings
16
Buy
0
Hold
0
Sell
Gebaseerd op 16 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.
By Trading Central
Korte Termijn
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Gemiddeld Termijn
Bearish Evidence
All events are bearish.
Lange Termijn
Strong Bearish Evidence
All events are bearish.
By Acuity
Nieuwssentiment
Neutral
Volatiliteit
Onder gemiddelde
Nieuws Volume (RCV)
Gemiddelde
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$